JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer

Clinical trial NCT07336771 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07336771
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Locally Advanced Breast Cancer (LABC)

Start date: 2026-01-01
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.